{"text": ["3", "Top", "Biotech", "Stocks", "to", "Buy", "in", "October"], "created_at": "2018-10-08 23:06:59"}
{"text": ["3", "Top", "Biotech", "Stocks", "to", "Buy", "in", "October"], "created_at": "2018-10-08 23:06:59"}
{"text": ["3", "Top", "Biotech", "Stocks", "to", "Buy", "in", "October"], "created_at": "2018-10-08 21:14:00"}
{"text": ["SHAREHOLDER", "ALERT:", "SKX", "PM", "USAT", "MCHP", "ABBV", "ALNY", "MGTI", "CPB", "CHGG", "ADNT:", "The", "Law", "Offices", "of", "Vincent", "Wong", "Reminds", "Investors", "of", "Important", "Class", "Action", "Deadlines"], "created_at": "2018-10-08 20:35:27"}
{"text": ["AbbVie's", "Orilissa", "Gets", "Canadian", "Nod", "to", "Treat", "Endometriosis"], "created_at": "2018-10-08 18:06:30"}
{"text": ["AbbVie's", "Orilissa", "Gets", "Canadian", "Nod", "to", "Treat", "Endometriosis"], "created_at": "2018-10-08 18:06:30"}
{"text": ["AbbVie&apos;s", "Orilissa", "Gets", "Canadian", "Nod", "to", "Treat", "Endometriosis"], "created_at": "2018-10-08 15:51:03"}
{"text": ["AbbVie", "to", "Present", "New", "Data", "for", "Upadacitinib", "and", "HUMIRA\u00ae", "(adalimumab)", "at", "the", "2018", "ACR/ARHP", "Annual", "Meeting"], "created_at": "2018-10-08 12:33:00"}
